Guanli Huang
- Cancer Research top 2%
- Cancer-related molecular mechanisms research 7
- MicroRNA in disease regulation 5
- Molecular Biology top 10%
- Circular RNAs in diseases 4
- Advanced biosensing and bioanalysis techniques 2
- RNA modifications and cancer 2
-
- Thyroid Cancer Diagnosis and Treatment 5
-
- Head and Neck Anomalies 2
-
- Ferroptosis and cancer prognosis 2
- Partner nations
- ChinaUnited States
In The Last Decade
Guanli Huang
19 papers receiving 973 citations
Peers
Comparison fields: 5 of 63
- Cancer Research 756
- Molecular Biology 831
- Oncology 79
- Pathology and Forensic Medicine 51
- Endocrinology, Diabetes and Metabolism 41
Countries citing papers authored by Guanli Huang
This map shows the geographic impact of Guanli Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guanli Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guanli Huang more than expected).
Fields of papers citing papers by Guanli Huang
This network shows the impact of papers produced by Guanli Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guanli Huang. The network helps show where Guanli Huang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Guanli Huang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 1 | |
| 2 | 2022 | 2 | |
| 3 | 2022 | 18 | |
| 4 | 2022 | 24 | |
| 5 | 2020 | 6 | |
| 6 | 2016 | 43 | |
| 7 | 2016 | 140 | |
| 8 | 2016 | 13 | |
| 9 | 2016 | 30 | |
| 10 | 2015 | 16 | |
| 11 | 2015 | 38 | |
| 12 | 2015 | 263 | |
| 13 | 2013 | 65 | |
| 14 | 2012 | 26 | |
| 15 | 2012 | 30 | |
| 16 | 2012 | 136 | |
| 17 | 2012 | 24 | |
| 18 | Clinical significance of miR-21 expression in breast cancer: SYBR-Green I-based real-time RT-PCR study of invasive ductal carcinoma. | 2009 | 98 |
| 19 | [Expression of microRNA-21 in invasive ductal carcinoma of the breast and its association with phosphatase and tensin homolog deleted from chromosome expression and clinicopathologic features]. | 2008 | 14 |
About Guanli Huang
Guanli Huang is a scholar working on Cancer Research, Endocrinology, Diabetes and Metabolism and Otorhinolaryngology, having authored 19 papers that have together received 987 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (5 papers), Thyroid Cancer Diagnosis and Treatment (5 papers), Circular RNAs in diseases (4 papers), Head and Neck Anomalies (2 papers), Ferroptosis and cancer prognosis (2 papers), Advanced biosensing and bioanalysis techniques (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Cancer Research (756 citations), Molecular Biology (831 citations) and Oncology (79 citations). Guanli Huang has collaborated with scholars based in China and United States. Frequent co-authors include Xiangjian Chen, Hua Zhu, Yixiong Shi, Huajie Cai, Wenzhi Wu, Guilong Guo, Xian Shen, Xiaoli Wu, Xiaohua Zhang and Zhu Hua. Their work appears in journals such as PLoS ONE, Scientific Reports and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.